SeekingAlpha · Aug 13, 2026
CapsoVision, Inc. (CV) Q2 2026 Earnings Call Transcript
CapsoVision, Inc. (CV) Q2 2026 Earnings Call August 13, 2026 4:30 PM EDTCompany ParticipantsLeigh SalvoKang Wang - Co-Founder, President, CEO &...
CV
NASDAQ · CV
CapsoVision, Inc.
Healthcare · Medical - Equipment & Services
$6.15
Down-$0.30 (-4.58%)
Updated Aug 19, 2026, 10:16 AM
SID Score
4.2/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 674.03M
- P/E ratio
- -28.7
- Dividend yield
- 0.00%
- 52-week range
- $4.74 – $9.17
- Volume
- 150.82K
- Avg. volume
- 80.82K
Price performance
CV price history
1M range · 21 trading sessions · Daily adjusted prices
CV closed at $6.15 after 21 trading sessions, down 12.39% for the selected period.
- Last close
- $6.15
- Period change
- -12.39%
- Period low
- $6.15
- Period high
- $7.17
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 18, 2026 | $6.40 | $6.52 | $6.03 | $6.15 | 150.82K |
| Aug 17, 2026 | $6.28 | $6.755 | $6.28 | $6.445 | 69.21K |
| Aug 14, 2026 | $6.50 | $6.68 | $6.10 | $6.46 | 151.84K |
| Aug 13, 2026 | $6.91 | $7.00 | $6.72 | $6.79 | 74.21K |
| Aug 12, 2026 | $6.61 | $6.96 | $6.53 | $6.86 | 95.41K |
| Aug 11, 2026 | $6.69 | $6.74 | $6.51 | $6.60 | 79.73K |
| Aug 10, 2026 | $7.00 | $7.00 | $6.66 | $6.68 | 90.01K |
| Aug 7, 2026 | $6.98 | $7.18 | $6.965 | $7.10 | 113.66K |
| Aug 6, 2026 | $6.70 | $6.995 | $6.55 | $6.90 | 69.63K |
| Aug 5, 2026 | $6.91 | $6.94 | $6.4145 | $6.77 | 139.37K |
| Aug 4, 2026 | $7.16 | $7.33 | $6.82 | $6.94 | 120.75K |
| Aug 3, 2026 | $6.71 | $7.22 | $6.71 | $7.17 | 114.01K |
| Jul 31, 2026 | $6.67 | $6.72 | $6.54 | $6.58 | 66.29K |
| Jul 30, 2026 | $6.69 | $6.805 | $6.545 | $6.70 | 68.83K |
| Jul 29, 2026 | $6.62 | $6.90 | $6.62 | $6.63 | 113.08K |
| Jul 28, 2026 | $6.69 | $6.70 | $6.5126 | $6.62 | 57.36K |
| Jul 27, 2026 | $6.58 | $6.78 | $6.54 | $6.61 | 83.71K |
| Jul 24, 2026 | $6.65 | $6.765 | $6.40 | $6.49 | 70.41K |
| Jul 23, 2026 | $6.83 | $6.95 | $6.48 | $6.60 | 109.85K |
| Jul 22, 2026 | $7.12 | $7.12 | $6.82 | $6.91 | 106.13K |
| Jul 21, 2026 | $6.76 | $7.10 | $6.73 | $7.02 | 101.62K |
Latest CV news
The latest Smart Investors Daily articles mentioning CV.
Stock researchCompany · Overview
CV research
Overview
Company profile and research snapshot.
Company profile
CapsoVision Inc is a commercial-stage medical technology enterprise, innovates, manufactures, and markets endoscopic video imaging devices focused on internal imaging of the gastrointestinal (GI) system. Internal GI imaging facilitates earlier detection of colorectal cancer and other diseases, enabling more timely and effective treatment regimens for patients. The Company's core technology platform is an orally ingestable capsule including multiple cameras facilitating 360-degree imaging, light-emitting diodes for measurement, onboard memory storage, and battery life permitting recording and onboard storage of video images. The Company's products consist of the on-market CapsoCam Plus, directed at the small intestines, and the in-development CapsoColon 3D directed at the large intestines.
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- —
- Average target
- $7.00
- Implied upside
- —
- Analysts
- —
| Date | Firm | Rating | Target |
|---|---|---|---|
| Mar 27, 2026 | Benchmark | Speculative Buy | — |
| Dec 31, 2025 | Benchmark | Speculative Buy | — |
| Jul 28, 2025 | Benchmark | Speculative Buy | — |
News briefing
No generated briefing is available yet.
Benzinga · Aug 13, 2026
CapsoVision Q2 2026 Earnings Call Transcript
CapsoVision (NASDAQ:CV) released second-quarter financial results and hosted an earnings call on Thursday. Read the complete transcript below. Benzinga APIs provide real-time access to earnings call transcripts and
Benzinga · Aug 13, 2026
CapsoVision Files Prospectus For Up To $250M Offering Of Common Stock, Preferred Stock, Warrants, Rights And Units
CapsoVision, Inc.$250,000,000Common StockPreferred StockWarrantsRightsUnits From time to time, we may offer to sell the securities described in this prospectus separately or together in any combination, in one or
Benzinga · Aug 13, 2026
CapsoVision Enters Sales Agreement With Cantor FitzGerald For ATM Offering Up To $100M
-SEC Filing
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
